Treatments for secondary hyperparathyroidism in hemodialysis

Intensification of Anemia by Secondary Hyperparathyroidism in Hemodialysis Patients

The excessive amounts of parathyroid hormone in secondary hyperparathyroidism (SHPTH) is suggested to interfere with normal erythropoiesis.  In SHPTH, during chronic renal failure, due to the impairment of erythropoietin synthesis, this effect is more pronounced.  In the present study the role of secondary hyperparathyroidism in the severity of anemia was evaluated in hemodialysis patients (n=3...

Management of Secondary Hyperparathyroidism in Hemodialysis Patients

Leontiasis Ossea Following Secondary Hyperparathyroidism and Hemodialysis

Leontiasis ossea is a rare medical condition which is characterized by an overgrowth of the facial and cranial bones secondary to chronic renal failure and secondary hyperparathyroidism. We reported a case of leontiasis ossea with history of secondary hyperparathyroidism due to end-stage renal disease on regular hemodialysis. A 37-year-old female with end-stage renal disease from lupus disease ...

Hemodialysis patients’ preferences for the management of secondary hyperparathyroidism

BACKGROUND Patient engagement and patient-centered care are critical in optimally managing patients with end-stage renal disease (ESRD). Understanding patient preferences is a key element of patient-centered care and shared decision making. The objective of this study was to elicit patients' preferences for the treatment of secondary hyperparathyroidism (SHPT) associated with ESRD using a discr...

intensification of anemia by secondary hyperparathyroidism in hemodialysis patients

the excessive amounts of parathyroid hormone in secondary hyperparathyroidism (shpth) is suggested to interfere with normal erythropoiesis.  in shpth, during chronic renal failure, due to the impairment of erythropoietin synthesis, this effect is more pronounced.  in the present study the role of secondary hyperparathyroidism in the severity of anemia was evaluated in hemodialysis patients (n=3...